Research infrastructure for clinical trials of mRNA-based vaccines and/or therapeutics
MRFF 2021 mRNA Clinical Trial Enabling Infrastructure Grant OpportunityLast Updated: 22 July 2022
This information reflects the previous government. It is in the process of being updated.
MRFF 2021 mRNA Clinical Trial Enabling Infrastructure Grant Opportunity
This program is expected to be open for applications in March 2022.
What do you get?
A fixed grant amount of $5 million over 3 years from 2022-23 to develop our onshore mRNA vaccine manufacturing capability.
Who is this for?
An eligible organisation who applied to the Department of Industry, Science, Energy and Resources (DISER) and Department of Health’s 'Approach To Market: Enabling Australia’s onshore mRNA manufacturing capability' program and who can partner with least one state government partner organisation contributing to the research.
Overview
The 2021 mRNA Clinical Trial Enabling Infrastructure grant is part of the Medical Research Future Fund (MRFF) and the Coronavirus Research response. This opportunity looks to fund an organisation who has applied to the Department of Industry, Science, Energy and Resources (DISER) and Department of Health’s Approach To Market: Enabling Australia’s onshore mRNA manufacturing capability. In addition, they must specify at least one state government partner organisation contributing to the research.
The objective of this grant opportunity is to provide funding to Australian medical research and medical innovation projects that leverage and enhance emerging technologies, platforms, equipment and infrastructure to conduct clinical trials of mRNA-based vaccines and/or therapeutics.
Contact
Need help?
-
Let us answer your question via phone, email or webchat. And if we can't help, we'll put you in touch with someone who can.
-
Monday – Friday, 8am – 8pm across Australia
